Evirent - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | - | - | - | - | 125,399 | 514,468 | 557,359 |
| Profit before tax | 211,536 | 11,095 | 18,616 | 15,713 | 11,745 | -63,331 | 49,813 | 52,166 |
| Net profit | 208,129 | 9,431 | 15,824 | 13,356 | 9,983 | -63,331 | 47,567 | 48,363 |
| Equity | 952,134 | 961,565 | 977,389 | 990,745 | 1,000,728 | 937,397 | 984,964 | 1,033,327 |
| Liabilities | 13,923,807 | 1,072,814 | 1,088,417 | 1,100,357 | 1,076,816 | 4,047,651 | 6,380,370 | 8,687,291 |
| Non-current assets | 14,187,000 | 1,881,258 | 1,910,332 | 1,975,000 | 800,725 | 4,702,848 | 7,294,672 | 9,350,772 |
| Current assets | 688,941 | 153,121 | 155,474 | 116,102 | 1,276,819 | 282,200 | 70,662 | 369,846 |
| Total assets | 14,875,941 | 2,034,379 | 2,065,806 | 2,091,102 | 2,077,544 | 4,985,048 | 7,365,334 | 9,720,618 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,388 | 556,153 | 80,886 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | - | - | - | - | +310.3% | +8.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.4% | 0.5% | 0.8% | 0.6% | 0.5% | -1.3% | 0.6% | 0.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 21.9% | 1.0% | 1.6% | 1.3% | 1.0% | -6.8% | 4.8% | 4.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | - | -50.5% | 9.2% | 8.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | -50.5% | 9.7% | 9.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 14.6 | 1.1 | 1.1 | 1.1 | 1.1 | 4.3 | 6.5 | 8.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | 125,399 | 514,468 | 557,359 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Evirent - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-17 | 2026-05-20 | 0.07 |
Evirent - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-07-30 | 2026-08-19 | 0.22 |
| 2026-07-01 | 2026-07-07 | 73.94 |
| 2026-06-28 | 2026-06-30 | 73.84 |
| 2026-02-21 | 2026-02-21 | 24674.68 |
| 2026-02-14 | 2026-02-20 | 55.41 |
| 2025-08-28 | 2025-09-01 | 0.21 |
| 2025-02-28 | 2025-03-03 | 0.32 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Evirent, UAB, code 111740615, is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €557.4K, up 8.3% year on year from €514.5K in 2024 and well above €125.4K in 2023, which indicates strong two-year growth. Net profit in 2025 reached €48.4K, slightly above €47.6K in 2024, after a loss of €63.3K in 2023. The profit margin remained positive at 8.7%, compared with 9.2% in 2024. Total assets increased to €9.72M in 2025 from €7.37M a year earlier and €4.99M in 2023, while equity rose modestly to €1.03M. Liabilities expanded to €8.69M, keeping the equity ratio at 10.6% and debt-to-equity at 8.41. The asset base is dominated by long-term assets, and asset turnover remained low at 0.06x. Return on equity was 4.7% and return on assets 0.5%. Revenue per employee was €557.4K in 2025.